Go Pro
→ Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid (From Altimetry) (Ad)tc pixel Free CO Stock Alerts

Global Cord Blood (CO) Competitors

Global Cord Blood logo
$0.95 +0.00 (+0.26%)
As of 09/3/2026
Compare

CO vs. SBC, CYH, AUNA, TACO, and VMD

Should you buy Global Cord Blood stock or one of its competitors? Global Cord Blood's main competitors and comparable companies include SBC Medical Group (SBC), Community Health Systems (CYH), Auna (AUNA), Berto Acquisition (TACO), and Viemed Healthcare (VMD). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare providers & services" industry.

How does Global Cord Blood compare to SBC Medical Group?

Global Cord Blood (NYSE:CO) and SBC Medical Group (NASDAQ:SBC) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, dividends, risk, earnings, media sentiment and valuation.

SBC Medical Group has a net margin of 27.99% compared to Global Cord Blood's net margin of 0.00%. SBC Medical Group's return on equity of 18.47% beat Global Cord Blood's return on equity.

Company Net Margins Return on Equity Return on Assets
Global Cord BloodN/A N/A N/A
SBC Medical Group 27.99%18.47%13.10%

In the previous week, SBC Medical Group had 3 more articles in the media than Global Cord Blood. MarketBeat recorded 3 mentions for SBC Medical Group and 0 mentions for Global Cord Blood. SBC Medical Group's average media sentiment score of 0.62 beat Global Cord Blood's score of 0.00 indicating that SBC Medical Group is being referred to more favorably in the news media.

Company Overall Sentiment
Global Cord Blood Neutral
SBC Medical Group Positive

Global Cord Blood has higher revenue and earnings than SBC Medical Group. Global Cord Blood is trading at a lower price-to-earnings ratio than SBC Medical Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Global Cord Blood$1.24B0.09$79.04M$0.641.49
SBC Medical Group$173.61M2.44$50.99M$0.478.77

60.8% of SBC Medical Group shares are held by institutional investors. 0.5% of Global Cord Blood shares are held by company insiders. Comparatively, 81.7% of SBC Medical Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Global Cord Blood has a beta of 0.16, meaning that its stock price is 84% less volatile than the broader market. Comparatively, SBC Medical Group has a beta of 0.63, meaning that its stock price is 37% less volatile than the broader market.

SBC Medical Group has a consensus target price of $8.50, indicating a potential upside of 106.31%. Given SBC Medical Group's stronger consensus rating and higher possible upside, analysts clearly believe SBC Medical Group is more favorable than Global Cord Blood.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Global Cord Blood
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
SBC Medical Group
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33

Summary

SBC Medical Group beats Global Cord Blood on 13 of the 16 factors compared between the two stocks.

How does Global Cord Blood compare to Community Health Systems?

Community Health Systems (NYSE:CYH) and Global Cord Blood (NYSE:CO) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, analyst recommendations, media sentiment, dividends, risk, earnings, valuation and institutional ownership.

85.0% of Community Health Systems shares are held by institutional investors. 11.1% of Community Health Systems shares are held by insiders. Comparatively, 0.5% of Global Cord Blood shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Community Health Systems presently has a consensus target price of $2.95, suggesting a potential upside of 2.43%. Given Community Health Systems' stronger consensus rating and higher possible upside, research analysts plainly believe Community Health Systems is more favorable than Global Cord Blood.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Community Health Systems
3 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
1.71
Global Cord Blood
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Community Health Systems has a net margin of 2.10% compared to Global Cord Blood's net margin of 0.00%. Global Cord Blood's return on equity of 0.00% beat Community Health Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
Community Health Systems2.10% -6.66% 0.62%
Global Cord Blood N/A N/A N/A

In the previous week, Community Health Systems had 6 more articles in the media than Global Cord Blood. MarketBeat recorded 6 mentions for Community Health Systems and 0 mentions for Global Cord Blood. Community Health Systems' average media sentiment score of 0.96 beat Global Cord Blood's score of 0.00 indicating that Community Health Systems is being referred to more favorably in the media.

Company Overall Sentiment
Community Health Systems Positive
Global Cord Blood Neutral

Community Health Systems has a beta of 1.86, suggesting that its stock price is 86% more volatile than the broader market. Comparatively, Global Cord Blood has a beta of 0.16, suggesting that its stock price is 84% less volatile than the broader market.

Community Health Systems has higher revenue and earnings than Global Cord Blood. Global Cord Blood is trading at a lower price-to-earnings ratio than Community Health Systems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Community Health Systems$12.49B0.03$509M$1.851.56
Global Cord Blood$1.24B0.09$79.04M$0.641.49

Summary

Community Health Systems beats Global Cord Blood on 14 of the 16 factors compared between the two stocks.

How does Global Cord Blood compare to Auna?

Auna (NYSE:AUNA) and Global Cord Blood (NYSE:CO) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, risk, valuation, earnings, institutional ownership, analyst recommendations, profitability and media sentiment.

Auna has a beta of 0.62, meaning that its share price is 38% less volatile than the broader market. Comparatively, Global Cord Blood has a beta of 0.16, meaning that its share price is 84% less volatile than the broader market.

In the previous week, Auna had 1 more articles in the media than Global Cord Blood. MarketBeat recorded 1 mentions for Auna and 0 mentions for Global Cord Blood. Auna's average media sentiment score of 0.51 beat Global Cord Blood's score of 0.00 indicating that Auna is being referred to more favorably in the media.

Company Overall Sentiment
Auna Positive
Global Cord Blood Neutral

Auna has a net margin of 0.44% compared to Global Cord Blood's net margin of 0.00%. Auna's return on equity of 12.88% beat Global Cord Blood's return on equity.

Company Net Margins Return on Equity Return on Assets
Auna0.44% 12.88% 3.24%
Global Cord Blood N/A N/A N/A

Auna currently has a consensus target price of $6.97, suggesting a potential upside of 31.45%. Given Auna's stronger consensus rating and higher possible upside, analysts clearly believe Auna is more favorable than Global Cord Blood.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Auna
1 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.40
Global Cord Blood
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Global Cord Blood has higher revenue and earnings than Auna. Global Cord Blood is trading at a lower price-to-earnings ratio than Auna, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Auna$1.23B0.32$27.39M$0.0775.71
Global Cord Blood$1.24B0.09$79.04M$0.641.49

Summary

Auna beats Global Cord Blood on 12 of the 15 factors compared between the two stocks.

How does Global Cord Blood compare to Berto Acquisition?

Berto Acquisition (NASDAQ:TACO) and Global Cord Blood (NYSE:CO) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, dividends, risk, profitability, institutional ownership and media sentiment.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Berto Acquisition
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Global Cord Blood
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Berto Acquisition has a beta of 0.08, indicating that its stock price is 92% less volatile than the broader market. Comparatively, Global Cord Blood has a beta of 0.16, indicating that its stock price is 84% less volatile than the broader market.

Global Cord Blood has higher revenue and earnings than Berto Acquisition.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Berto AcquisitionN/AN/AN/AN/AN/A
Global Cord Blood$1.24B0.09$79.04M$0.641.49

In the previous week, Berto Acquisition's average media sentiment score of 1.95 beat Global Cord Blood's score of 0.00 indicating that Berto Acquisition is being referred to more favorably in the media.

Company Overall Sentiment
Berto Acquisition Very Positive
Global Cord Blood Neutral

Company Net Margins Return on Equity Return on Assets
Berto AcquisitionN/A N/A N/A
Global Cord Blood N/A N/A N/A

Summary

Berto Acquisition and Global Cord Blood tied by winning 2 of the 4 factors compared between the two stocks.

How does Global Cord Blood compare to Viemed Healthcare?

Global Cord Blood (NYSE:CO) and Viemed Healthcare (NASDAQ:VMD) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, profitability, earnings, valuation and media sentiment.

Global Cord Blood has higher revenue and earnings than Viemed Healthcare. Global Cord Blood is trading at a lower price-to-earnings ratio than Viemed Healthcare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Global Cord Blood$1.24B0.09$79.04M$0.641.49
Viemed Healthcare$270.28M1.28$14.93M$0.3625.22

In the previous week, Viemed Healthcare had 4 more articles in the media than Global Cord Blood. MarketBeat recorded 4 mentions for Viemed Healthcare and 0 mentions for Global Cord Blood. Viemed Healthcare's average media sentiment score of 1.63 beat Global Cord Blood's score of 0.00 indicating that Viemed Healthcare is being referred to more favorably in the news media.

Company Overall Sentiment
Global Cord Blood Neutral
Viemed Healthcare Very Positive

Viemed Healthcare has a net margin of 4.81% compared to Global Cord Blood's net margin of 0.00%. Viemed Healthcare's return on equity of 10.16% beat Global Cord Blood's return on equity.

Company Net Margins Return on Equity Return on Assets
Global Cord BloodN/A N/A N/A
Viemed Healthcare 4.81%10.16%7.22%

Viemed Healthcare has a consensus target price of $14.00, indicating a potential upside of 54.19%. Given Viemed Healthcare's stronger consensus rating and higher probable upside, analysts plainly believe Viemed Healthcare is more favorable than Global Cord Blood.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Global Cord Blood
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Viemed Healthcare
0 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.25

74.2% of Viemed Healthcare shares are owned by institutional investors. 0.5% of Global Cord Blood shares are owned by company insiders. Comparatively, 20.6% of Viemed Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Global Cord Blood has a beta of 0.16, suggesting that its share price is 84% less volatile than the broader market. Comparatively, Viemed Healthcare has a beta of 1.09, suggesting that its share price is 9% more volatile than the broader market.

Summary

Viemed Healthcare beats Global Cord Blood on 13 of the 16 factors compared between the two stocks.

Get Global Cord Blood News Delivered to You Automatically

Sign up to receive the latest news and ratings for CO and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CO vs. The Competition

Export
MetricGlobal Cord BloodHealthcare Providers & Services IndustryHealthcare SectorNYSE Exchange
Market Cap$115.89M$10.10B$7.28B$23.69B
Dividend YieldN/A2.59%2.53%3.72%
P/E Ratio1.4934.60272.4329.32
Price / Sales0.094.95617.3720.78
Price / Cash4.19121.7577.3933.23
Price / Book0.153.9912.857.60
Net Income$79.04M$313.25M$3.47B$1.07B
7 Day PerformanceN/A1.06%0.97%-0.05%
1 Month Performance0.26%0.33%5.46%-0.24%
1 Year PerformanceN/A15.31%24.28%12.79%

Global Cord Blood Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CO
Global Cord Blood
N/A$0.95
+0.3%		N/A-9.2%$115.89M$1.24B1.491,202
SBC
SBC Medical Group
4.1113 of 5 stars		$4.08
-0.7%		$8.50
+108.3%		+1.2%$419.63M$173.61M8.68N/A
CYH
Community Health Systems
1.888 of 5 stars		$2.89
-1.4%		$2.95
+2.1%		+1.2%$407.52M$12.49B1.5657,000
AUNA
Auna
4.3412 of 5 stars		$5.11
flat		$6.97
+36.3%		-16.5%$378.19M$1.23B73.0115,254
TACO
Berto Acquisition
0.9777 of 5 stars		$10.48
+0.1%		N/A+1.8%$341.86MN/AN/A7,892

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NYSE:CO) was last updated on 9/5/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel